We also measured the expression of CTLA-4 and PD-L1 genes in PBMC samples of RR-MS patients who received various treatments of Fingolimod, IFNβ-1α, GA, and DMF and compared them with samples of naïve patients (Figure 3B and Figure 4B). Here, CTLA4 is linked to myeloid sarcoma.